Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-08-07 | Amended | $1,715,000 | Unknown | Equity Only | SEC link | |
| 2025-08-01 | New | $1,300,000 | $1,300,000 | Equity Only | 06b 4a5 | SEC link |
| 2024-12-19 | New | $3,333,333 | $3,333,333 | Equity and Debt | 06b | SEC link |
| 2019-08-08 | New | $1,000,000 | $1,000,000 | Equity Only | 06b | SEC link |
| 2018-10-25 | New | $300,000 | $300,000 | Debt Only | 06b | SEC link |
| 2018-07-13 | New | $300,000 | $300,000 | Equity Only | 06b | SEC link |
| 2017-03-21 | New | $250,875 | $250,875 | Equity Only | 06b | SEC link |
| 2017-01-17 | New | $0 | $0 | Equity Only | 06b | SEC link |
| 2015-11-03 | New | $451,600 | $451,600 | Equity and Debt | 06b | SEC link |
| 2014-10-21 | New | $1,100,000 | $1,100,000 | Equity Only | 06b | SEC link |
| 2014-08-27 | New | $375,000 | $375,000 | Equity Only | 06b | SEC link |
| 2014-08-26 | New | $64,900,000 | $64,900,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Suren Ajjarapu | Director, Executive |
| Surendra Ajjarapu | Director, Executive |
| Mayur Doshi | Director |
| Howard Doss | Executive |
| Donald G. Fell | Director |
| Shankar Hariharan | Director, Executive |
| Subbarao Jayanthi | Director |
| Narasimhan Mani | Director, Executive |
| Prashant Patel | Director, Executive |
| Michael Peterson | Director |
| Charles L. Pope | Director |
| Fernando Sanchez | Director |